Scalper1 News
While the market still looks bearish, top-rated medical stocks including Biogen Idec and Alexion have remained strong as demand for new treatments and breakthroughs overcomes investor skittishness elsewhere. The latest IBD 50 list includes four thriving medical stocks that will report quarterly results this week. The outlook for all of them is healthy revenue and earnings growth vs. the same quarter a year ago. Biotech drugmaker Biogen Idec (BIIB) Scalper1 News
Scalper1 News